BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1677667)

  • 1. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
    Ludlam H; McCann M
    J Hosp Infect; 1991 Apr; 17(4):324-6. PubMed ID: 1677667
    [No Abstract]   [Full Text] [Related]  

  • 2. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
    Ludlam HA; Young AE; Berry AJ; Phillips I
    J Hosp Infect; 1989 Nov; 14(4):293-301. PubMed ID: 2575628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of vaccination in the prevention of staphylococcal peritonitis in continuous ambulatory peritoneal dialysis.
    Poole-Warren LA; Farrell PC
    Perit Dial Int; 1993; 13(3):176-7. PubMed ID: 8369344
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing infection with Staphylococcus aureus in CAPD.
    Ludlam H; Tremlett CH; Wilson AP
    Perit Dial Int; 1997; 17(4):405-6. PubMed ID: 9284476
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) by Y-connected double bag systems.
    Wüst J; Binswanger U; Bichsel G
    Life Support Syst; 1985; 3 Suppl 1():107-11. PubMed ID: 3870548
    [No Abstract]   [Full Text] [Related]  

  • 6. Audit of infection in continuous ambulatory peritoneal dialysis.
    Wilson AP; Scott GM; Lewis C; Neild G; Rudge C
    J Hosp Infect; 1994 Dec; 28(4):265-71. PubMed ID: 7897188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of peritonitis in continuous ambulatory peritoneal dialysis. Comparative study of 2 different protocols of training and bag changing].
    Selgas R; Pérez-Fontán M; Miguel JL; Rodríguez-Carmona A; Zuzuarregui MS; Escuin F; Ortega O; Conesa J; Huarte E; Sánchez Sicilia L
    Med Clin (Barc); 1984 Oct; 83(12):482-4. PubMed ID: 6513621
    [No Abstract]   [Full Text] [Related]  

  • 8. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
    Luzar MA
    Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 10. Peritonitis during continuous ambulatory peritoneal dialysis: improving patient defense by type of buffer of dialysate?
    Binswanger U; Keusch G; Bammatter F; Heule H; Kiss D
    Nephron; 1981; 28(6):300-2. PubMed ID: 7312085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD.
    Glancey GR; Cameron JS; Ogg CS
    Nephrol Dial Transplant; 1992; 7(7):627-31. PubMed ID: 1323074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CAPD peritonitis rate is not improving with time.
    Fenton SS; Pei Y; Delmore T; Cattran DC; Bowman C; Johnston N; Campbell I; Clarke WT; Richardson RM
    ASAIO Trans; 1986; 32(1):546-9. PubMed ID: 3778765
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of peritonitis in continuous ambulatory peritoneal dialysis.
    Ludlam H; Dryden M; Wing AJ; Phillips I
    Lancet; 1990 May; 335(8698):1161. PubMed ID: 1971893
    [No Abstract]   [Full Text] [Related]  

  • 17. Peritonitis due to Staphylococcus sciuri in a patient on continuous ambulatory peritoneal dialysis.
    Wallet F; Stuit L; Boulanger E; Roussel-Delvallez M; Dequiedt P; Courcol RJ
    Scand J Infect Dis; 2000; 32(6):697-8. PubMed ID: 11200385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.
    Zimmerman SW; Ahrens E; Johnson CA; Craig W; Leggett J; O'Brien M; Oxton L; Roecker EB; Engeseth S
    Am J Kidney Dis; 1991 Aug; 18(2):225-31. PubMed ID: 1867179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.